Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

83 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Nanoimmunotherapy to treat ischaemic heart disease.
Duivenvoorden R, Senders ML, van Leent MMT, Pérez-Medina C, Nahrendorf M, Fayad ZA, Mulder WJM. Duivenvoorden R, et al. Nat Rev Cardiol. 2019 Jan;16(1):21-32. doi: 10.1038/s41569-018-0073-1. Nat Rev Cardiol. 2019. PMID: 30209355 Free PMC article. Review.
Efficacy and safety assessment of a TRAF6-targeted nanoimmunotherapy in atherosclerotic mice and non-human primates.
Lameijer M, Binderup T, van Leent MMT, Senders ML, Fay F, Malkus J, Sanchez-Gaytan BL, Teunissen AJP, Karakatsanis N, Robson P, Zhou X, Ye Y, Wojtkiewicz G, Tang J, Seijkens TTP, Kroon J, Stroes ESG, Kjaer A, Ochando J, Reiner T, Pérez-Medina C, Calcagno C, Fisher EA, Zhang B, Temel RE, Swirski FK, Nahrendorf M, Fayad ZA, Lutgens E, Mulder WJM, Duivenvoorden R. Lameijer M, et al. Among authors: duivenvoorden r. Nat Biomed Eng. 2018 May;2(5):279-292. doi: 10.1038/s41551-018-0221-2. Epub 2018 Apr 16. Nat Biomed Eng. 2018. PMID: 30936448 Free PMC article.
Imaging-assisted nanoimmunotherapy for atherosclerosis in multiple species.
Binderup T, Duivenvoorden R, Fay F, van Leent MMT, Malkus J, Baxter S, Ishino S, Zhao Y, Sanchez-Gaytan B, Teunissen AJP, Frederico YCA, Tang J, Carlucci G, Lyashchenko S, Calcagno C, Karakatsanis N, Soultanidis G, Senders ML, Robson PM, Mani V, Ramachandran S, Lobatto ME, Hutten BA, Granada JF, Reiner T, Swirski FK, Nahrendorf M, Kjaer A, Fisher EA, Fayad ZA, Pérez-Medina C, Mulder WJM. Binderup T, et al. Among authors: duivenvoorden r. Sci Transl Med. 2019 Aug 21;11(506):eaaw7736. doi: 10.1126/scitranslmed.aaw7736. Sci Transl Med. 2019. PMID: 31434756 Free PMC article.
Probing myeloid cell dynamics in ischaemic heart disease by nanotracer hot-spot imaging.
Senders ML, Meerwaldt AE, van Leent MMT, Sanchez-Gaytan BL, van de Voort JC, Toner YC, Maier A, Klein ED, Sullivan NAT, Sofias AM, Groenen H, Faries C, Oosterwijk RS, van Leeuwen EM, Fay F, Chepurko E, Reiner T, Duivenvoorden R, Zangi L, Dijkhuizen RM, Hak S, Swirski FK, Nahrendorf M, Pérez-Medina C, Teunissen AJP, Fayad ZA, Calcagno C, Strijkers GJ, Mulder WJM. Senders ML, et al. Among authors: duivenvoorden r. Nat Nanotechnol. 2020 May;15(5):398-405. doi: 10.1038/s41565-020-0642-4. Epub 2020 Apr 20. Nat Nanotechnol. 2020. PMID: 32313216 Free PMC article.
Targeting Trained Innate Immunity With Nanobiologics to Treat Cardiovascular Disease.
Teunissen AJP, van Leent MMT, Prévot G, Brechbühl EES, Pérez-Medina C, Duivenvoorden R, Fayad ZA, Mulder WJM. Teunissen AJP, et al. Among authors: duivenvoorden r. Arterioscler Thromb Vasc Biol. 2021 Jun;41(6):1839-1850. doi: 10.1161/ATVBAHA.120.315448. Epub 2021 Apr 22. Arterioscler Thromb Vasc Biol. 2021. PMID: 33882685 Free PMC article. Review.
Safety of CETP inhibition.
Duivenvoorden R, Fayad ZA. Duivenvoorden R, et al. Curr Opin Lipidol. 2012 Dec;23(6):518-24. doi: 10.1097/MOL.0b013e32835916b3. Curr Opin Lipidol. 2012. PMID: 23010697 Review.
A statin-loaded reconstituted high-density lipoprotein nanoparticle inhibits atherosclerotic plaque inflammation.
Duivenvoorden R, Tang J, Cormode DP, Mieszawska AJ, Izquierdo-Garcia D, Ozcan C, Otten MJ, Zaidi N, Lobatto ME, van Rijs SM, Priem B, Kuan EL, Martel C, Hewing B, Sager H, Nahrendorf M, Randolph GJ, Stroes ES, Fuster V, Fisher EA, Fayad ZA, Mulder WJ. Duivenvoorden R, et al. Nat Commun. 2014;5:3065. doi: 10.1038/ncomms4065. Nat Commun. 2014. PMID: 24445279 Free PMC article.
Augmenting drug-carrier compatibility improves tumour nanotherapy efficacy.
Zhao Y, Fay F, Hak S, Manuel Perez-Aguilar J, Sanchez-Gaytan BL, Goode B, Duivenvoorden R, de Lange Davies C, Bjørkøy A, Weinstein H, Fayad ZA, Pérez-Medina C, Mulder WJ. Zhao Y, et al. Among authors: duivenvoorden r. Nat Commun. 2016 Apr 13;7:11221. doi: 10.1038/ncomms11221. Nat Commun. 2016. PMID: 27071376 Free PMC article.
83 results